Summary | |
---|---|
Symbol | PRTN3 |
Name | proteinase 3 |
Aliases | PR-3; ACPA; C-ANCA; AGP7; MBT; myeloblastin; serine proteinase, neutrophil; Wegener granulomatosis autoantig ...... |
Chromosomal Location | 19p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cytoplasmic granule Secreted Cell membrane Peripheral membrane protein Extracellular side Membrane raft Peripheral membrane protein Extracellular side Note=Localizes predominantly to azurophil granules (primary secretory granules) in neutrophils (PubMed:2033050, PubMed:3198760, PubMed:7897245, PubMed:18462208). Secreted upon neutrophil stimulation by TNF-alpha, lipopolysaccharide (LPS), fMLP and CXCL8/IL8 or during neutrophil transmigration (PubMed:22266279, PubMed:28240246). Following secretion tethered to the cell membrane by CD177 (PubMed:18462208, PubMed:22266279). |
Domain |
PF00089 Trypsin |
Function |
Serine protease that degrades elastin, fibronectin, laminin, vitronectin, and collagen types I, III, and IV (in vitro) (PubMed:3198760, PubMed:2033050, PubMed:28240246). By cleaving and activating receptor F2RL1/PAR-2, enhances endothelial cell barrier function and thus vascular integrity during neutrophil transendothelial migration (PubMed:23202369). May play a role in neutrophil transendothelial migration, probably when associated with CD177 (PubMed:22266279). |
Biological Process |
GO:0002521 leukocyte differentiation GO:0002573 myeloid leukocyte differentiation GO:0006909 phagocytosis GO:0007596 blood coagulation GO:0007599 hemostasis GO:0030099 myeloid cell differentiation GO:0030100 regulation of endocytosis GO:0030574 collagen catabolic process GO:0032963 collagen metabolic process GO:0044236 multicellular organism metabolic process GO:0044243 multicellular organism catabolic process GO:0044259 multicellular organismal macromolecule metabolic process GO:0045806 negative regulation of endocytosis GO:0050764 regulation of phagocytosis GO:0050765 negative regulation of phagocytosis GO:0050817 coagulation GO:0050878 regulation of body fluid levels GO:0051051 negative regulation of transport GO:0060627 regulation of vesicle-mediated transport GO:0097028 dendritic cell differentiation GO:0097029 mature conventional dendritic cell differentiation |
Molecular Function |
GO:0004175 endopeptidase activity GO:0004252 serine-type endopeptidase activity GO:0008236 serine-type peptidase activity GO:0017171 serine hydrolase activity |
Cellular Component | - |
KEGG | - |
Reactome |
R-HSA-6803157: Antimicrobial peptides R-HSA-140875: Common Pathway of Fibrin Clot Formation R-HSA-1280215: Cytokine Signaling in Immune system R-HSA-140877: Formation of Fibrin Clot (Clotting Cascade) R-HSA-109582: Hemostasis R-HSA-168256: Immune System R-HSA-168249: Innate Immune System R-HSA-6798695: Neutrophil degranulation R-HSA-449147: Signaling by Interleukins |
Summary | |
---|---|
Symbol | PRTN3 |
Name | proteinase 3 |
Aliases | PR-3; ACPA; C-ANCA; AGP7; MBT; myeloblastin; serine proteinase, neutrophil; Wegener granulomatosis autoantig ...... |
Chromosomal Location | 19p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between PRTN3 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | PRTN3 |
Name | proteinase 3 |
Aliases | PR-3; ACPA; C-ANCA; AGP7; MBT; myeloblastin; serine proteinase, neutrophil; Wegener granulomatosis autoantig ...... |
Chromosomal Location | 19p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of PRTN3 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | PRTN3 |
Name | proteinase 3 |
Aliases | PR-3; ACPA; C-ANCA; AGP7; MBT; myeloblastin; serine proteinase, neutrophil; Wegener granulomatosis autoantig ...... |
Chromosomal Location | 19p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of PRTN3 in various data sets.
|
Points in the above scatter plot represent the mutation difference of PRTN3 in various data sets.
|
Summary | |
---|---|
Symbol | PRTN3 |
Name | proteinase 3 |
Aliases | PR-3; ACPA; C-ANCA; AGP7; MBT; myeloblastin; serine proteinase, neutrophil; Wegener granulomatosis autoantig ...... |
Chromosomal Location | 19p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of PRTN3. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | PRTN3 |
Name | proteinase 3 |
Aliases | PR-3; ACPA; C-ANCA; AGP7; MBT; myeloblastin; serine proteinase, neutrophil; Wegener granulomatosis autoantig ...... |
Chromosomal Location | 19p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of PRTN3. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by PRTN3. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | PRTN3 |
Name | proteinase 3 |
Aliases | PR-3; ACPA; C-ANCA; AGP7; MBT; myeloblastin; serine proteinase, neutrophil; Wegener granulomatosis autoantig ...... |
Chromosomal Location | 19p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of PRTN3. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | PRTN3 |
Name | proteinase 3 |
Aliases | PR-3; ACPA; C-ANCA; AGP7; MBT; myeloblastin; serine proteinase, neutrophil; Wegener granulomatosis autoantig ...... |
Chromosomal Location | 19p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of PRTN3 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | PRTN3 |
Name | proteinase 3 |
Aliases | PR-3; ACPA; C-ANCA; AGP7; MBT; myeloblastin; serine proteinase, neutrophil; Wegener granulomatosis autoantig ...... |
Chromosomal Location | 19p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between PRTN3 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | PRTN3 |
Name | proteinase 3 |
Aliases | PR-3; ACPA; C-ANCA; AGP7; MBT; myeloblastin; serine proteinase, neutrophil; Wegener granulomatosis autoantig ...... |
Chromosomal Location | 19p13.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting PRTN3 collected from DrugBank database. |
Details on drugs targeting PRTN3.
|